Accretion Pharma Limited

ACCPL NSE Healthcare Pharmaceuticals

Strengths

  • Low debt: debt-to-equity of 0.23.
  • Comfortable interest cover: operating profit covers interest about 17.6 times.
  • Return on equity is healthy at 27.6%.
  • Return on capital employed is healthy at 28.9%.
  • Net profit margin is 10.8%.
  • Promoters hold a majority stake (73.52%).

!Watch-points

No notable watch-points flagged by the automated checks.

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
4.48

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreWeak
2 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 239 Cr
Current Price
High / Low₹ 215.00 / 53.80
Stock P/E24.70
Book Value₹ 49.20
Dividend Yield0.00%
ROCE28.90%
ROE27.60%
Face Value₹ 10.00
Debt to Equity0.23
PEG Ratio0.16
EV / EBITDA15.55
Industry PE35.70
P/B Ratio4.37
EPS₹ 8.70
Debt₹ 12 Cr
PAT Margin10.79%
Cash PAT₹ 11 Cr
ICR17.59
Promoter Holding73.52%
FII Holding0.00%
DII Holding2.76%
Public Holding23.72%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Educational data only. Not a recommendation to buy, sell or hold any security.